Effects of leuprorelin for the treatment of recurrent gynecological cancer by assessment including self-administered quality-of-life questionnaire 2019/01
2.
症例報告
Recurrent uterine serous carcinoma with a germline pathogenic BRCA2 variant treated using olaparib: A case report 2020/04
3.
原著
がん遺伝子パネル検査(クリニカルシーケンス)を実施した婦人科症例の検討 2021/02
4.
原著
Itraconazole increases resolvin E3 concentration and 12/15-lipoxygenase inhibitor attenuates its anticancer activity in cervical cancer cells 2021/09
5.
原著
Itraconazole Inhibits Intracellular Cholesterol Trafficking and Decreases Phosphatidylserine Level in Cervical Cancer Cells 2021/11
6.
原著
Metronomic chemotherapy using oral cyclophosphamide and bevacizumab for recurrent cervical cancer: A multi-institutional retrospective study 2022/05
7.
原著
当科におけるPARP阻害剤維持療法の現状 2022/10
8.
原著
Itraconazole Repolarizes Tumor-associated Macrophages and Suppresses Cervical Cancer Cell Growth 2023/02
9.
原著
Itraconazole Modulates Phospholipid Levels in Tumor-associated Macrophages 2023/03
10.
原著
Comprehensive Genomic Profiling Detects Hereditary Cancers and Confers Survival Advantage in Patients With Gynaecological Cancers 2023/05
11.
原著
Medroxyprogesterone as the Initial Systemic Treatment of Recurrent Endometrial Cancer: A Single Institutional Study 2023/06
12.
原著
Weight‑Loss Interventions and Levonorgestrel Intrauterine System Implantation for Early‑Stage Endometrial Cancer and Atypical Endometrial Hyperplasia to Reduce Perioperative Risk of Severely Obese Patients 2023/07
Bevacizumab with metronomic oral cyclophosphamide for patients with recurrent cervical cancer (Web発表,一般) 2021/04/25
23.
Rapid response to itraconazole and transcript analysis of the cervical cancer tissue obtained by the sequential biopsy: A case report (Web発表,一般) 2021/04/25
24.
Resolvin E3 : The mechanism of anti-cancer effect of itraconazole in cervical cancer (Web発表,一般) 2021/04/25